Advanced in Acute Myeloblastic Leukemia with Maturation

Nigel H. Russell

Guy's And St Thomas' NHS Foundation Trust
London, ENG, GB 
Advanced in Acute Myeloblastic Leukemia with Maturation
Guy's And St Thomas' NHS Foundation Trust
London, ENG, GB 
OverviewLocationsClinical Research

Overview

Nigel Russell practices in London, United Kingdom. Russell is rated as an Advanced expert by MediFind in the treatment of Acute Myeloblastic Leukemia with Maturation. Their top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Multiple Myeloma, and Bone Marrow Transplant.

Their clinical research consists of co-authoring 213 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Acute Myeloblastic Leukemia with Maturation.

Locations

Guy's and St Thomas' NHS Foundation Trust
London, ENG, United Kingdom
Other Locations
Nottingham, ENG, United Kingdom
Cambridge, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Multicenter Randomized Phase II Study to Evaluate the Efficacy of Prophylactic Transfer of CD4 Lymphocytes After T-cell Depleted Reduced Intensity HLA-Identical Sibling Transplantation for Haematological Cancers
Multicenter Randomized Phase II Study to Evaluate the Efficacy of Prophylactic Transfer of CD4 Lymphocytes After T-cell Depleted Reduced Intensity HLA-Identical Sibling Transplantation for Haematological Cancers
Enrollment Status: Unknown
Publish Date: February 12, 2019
Intervention Type: Other
Study Drug: CD4 Donor Lymphocytes
Study Phase: Phase 2
CMV TCR Gene Therapy: A Phase I Safety, Toxicity and Feasibility Study of Adoptive Immunotherapy With CMV TCR-transduced Donor-derived T Cells for Recipients of Allogeneic Haematopoietic Stem Cell Transplantation
CMV TCR Gene Therapy: A Phase I Safety, Toxicity and Feasibility Study of Adoptive Immunotherapy With CMV TCR-transduced Donor-derived T Cells for Recipients of Allogeneic Haematopoietic Stem Cell Transplantation
Enrollment Status: Suspended
Publish Date: September 12, 2018
Intervention Type: Genetic
Study Phase: Phase 1
View 1 Less Clinical Trial

213 Total Publications

Safety and Efficacy of Combining Midostaurin and Gemtuzumab Ozogamicin with Induction Chemotherapy in FLT3 mutated AML.
Safety and Efficacy of Combining Midostaurin and Gemtuzumab Ozogamicin with Induction Chemotherapy in FLT3 mutated AML.
Journal: Blood advances
Published: May 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Russell's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 23 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile